Foresite Capital Management II as of Dec. 31, 2014
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 19 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Universal American | 19.1 | $28M | 3.0M | 9.28 | |
| Orexigen Therapeutics | 18.1 | $27M | 4.4M | 6.06 | |
| Zafgen | 10.6 | $15M | 500k | 30.84 | |
| Auspex Pharmaceuticals | 6.2 | $9.0M | 172k | 52.48 | |
| BioDelivery Sciences International | 5.5 | $8.0M | 664k | 12.02 | |
| Alder Biopharmaceuticals | 4.9 | $7.1M | 245k | 29.09 | |
| Scynexis | 4.5 | $6.6M | 663k | 9.98 | |
| Aerie Pharmaceuticals | 4.4 | $6.4M | 220k | 29.19 | |
| Quotient | 4.0 | $5.9M | 328k | 18.00 | |
| Sage Therapeutics (SAGE) | 3.6 | $5.3M | 145k | 36.60 | |
| Juno Therapeutics | 3.3 | $4.8M | 92k | 52.22 | |
| T2 Biosystems | 3.0 | $4.4M | 228k | 19.24 | |
| Epizyme | 2.6 | $3.8M | 202k | 18.87 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 2.6 | $3.8M | 173k | 21.67 | |
| Anacor Pharmaceuticals | 2.4 | $3.4M | 107k | 32.25 | |
| Agile Therapeutics | 2.2 | $3.3M | 535k | 6.14 | |
| Bellicum Pharmaceuticals | 1.7 | $2.4M | 105k | 23.04 | |
| Ignyta | 1.3 | $1.9M | 275k | 6.85 | |
| Amedica | 0.1 | $180k | 225k | 0.80 |
